Rheumatoid Arthritis Clinical Trials in San Antonio

Showing 1861-1880 of 2,746 trials

Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

NCT03357471

The purpose of the study is to evaluate the ability of subjects who are already prescribed Certolizumab Pergol therapy and have been self injecting with prefilled syringes for at least the previous three months, to safely and effectively self-inject Certolizumab Pegol (CZP) using the e-Device and to evaluate the post-use structural integrity of used devices and cassettes via visual examination.

Moderate and Severe Active Rheumatoid ArthritisActive Psoriatic ArthritisActive Ankylosing Spondylitis+1 more

UCB Biopharma S.P.R.L.70 participantsStarted Nov 2017

Mesa, Arizona, United States • Mesa, Arizona, United States • Phoenix, Arizona, United States +19 more locations

COMPLETEDPhase 374 miles

A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic Keratoses

NCT02120898

The purpose of this study it so compare the safety and efficacy profiles of a generic imiquimod 2.5% cream to the reference listed Zyclara® (imiquimod) cream in the treatment of actinic keratosis (AK).

Actinic Keratosis

Actavis Inc.467 participantsStarted Oct 2013

Birmingham, Alabama, United States • Fremont, California, United States • Los Angeles, California, United States +24 more locations

Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic Keratoses

Rheumatoid Arthritis Trials in Other Cities

ImageReady(TM) MR Conditional Pacing System Clinical Study

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM")

Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis

Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients

Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)

SPRINT - Randomized Trial of Tibial Fracture Fixation

Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission

Post Market Surveillance Study of the Wingspan Stent System

Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder

A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer

LegDeb2 Global Registry for Use of Legflow in Peripheral Arteries

Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder

MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment

EPVent 2- A Phase II Study of Mechanical Ventilation Directed by Transpulmonary Pressures

A Clinical Trial of IntensiVE Dialysis

Other Conditions in San Antonio